BMS-824393
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-824393, covering 2011-03-15 to 2011-03-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I [Phase 2]